Home/AI/@metanova_labs

63

Score · promising

Scored 1mo ago · may be stale

@metanova_labs

METANOVA LABS

Metanova Labs is an early-stage decentralized AI drug discovery platform built on Bittensor (Subnet 68). They run continuous competitions for small molecule screening, nanobody design, and chemical search algorithms with daily rewards totaling ~$10k. The project has begun experimental validation partnerships (Yalotein for nanobody production) and maintains active technical development with regular algorithm improvements. Account is ~9 months old with <5k followers, positioning it as genuinely early-stage despite substantive technical activity.

𝕏 @metanova_labs ↗ t.co 📄 WhitepaperAIpromising

AI Analysispromising

Confidence

78%

Metanova Labs is an early-stage decentralized AI drug discovery platform built on Bittensor (Subnet 68).

They run continuous competitions for small molecule screening, nanobody design, and chemical search algorithms with daily rewards totaling ~$10k.

The project has begun experimental validation partnerships (Yalotein for nanobody production) and maintains active technical development with regular algorithm improvements.

Account is ~9 months old with <5k followers, positioning it as genuinely early-stage despite substantive technical activity.

Green flags: Real technical execution: regular subnet updates, filter improvements (BRENK), parallelization optimizations (20x molecule evaluations) · Experimental validation underway via partnership with Yalotein for nanobody production · Built on established infra (Bittensor Subnet 68) with transparent competition mechanics and daily rewards · Early-stage metrics: 4.5k followers, account created Nov 2024, not yet widely known outside Bittensor ecosystem · Credible team signal: CSO presenting at conferences, whitepaper available, professional website redesign

Red flags: Drug discovery is extremely long-horizon with uncertain commercial outcomes · Token utility and value capture mechanism not clearly explained in available data · Relatively low engagement (avg 120) given follower count suggests limited organic traction so far

Token

$NOVA · announced

Chain

Bittensor

Stage

mainnet+live

Category

DeSci drug discovery

Recent tweetsSee all on 𝕏 →

It’s only a matter of time before it becomes obvious to everyone that drug discovery is the best and potentially most rewarding use of compute and capital ↓ By then, we will have an unstoppable, increasingly automated system of incentive mechanisms connected with experimental validation optimizing different steps of the drug discovery process. We already have 3 competitions running around the clock (and more in the works), validation underway. Slowly then all at once. First mover advantage and early conviction compounds.

1w ago♥ 59💬 5🔁 5

New NOVA Blueprint winner Delivers 7.02× PSICHIC inference speedup from 214 → 1,502 protein–ligand pairs/sec on an RTX 3090 That means the same inference workload can be completed with ~86% less time and compute costs, allowing substantially more chemical space to be evaluated within the same budget. The winner also improves search by: Learning what to try next. Uncertainty-aware ranking directs search toward components that look promising while continuing to test those where evidence is limited. Optimizing the final set. Exact assembly selects the strongest 100-molecule set that satisfies Blueprint's diversity constraints. Next up: Boltz-2. NOVA Blueprint will now be scored using Boltz-2. We're excited to see how competitors optimize search around this more computationally intensive model.

1w ago♥ 50💬 4🔁 5

Build the next winning search algorithm: Boltz-2 is coming to NOVA Blueprint. The integration is now available for testing. With this release, Boltz-2 scoring moves to a dedicated GPU oracle rather than running inside the miner sandbox. Competitors can query the oracle throughout a run and use its predictions to guide and optimize their search. The challenge: how intelligently can you use a more powerful (and more computationally expensive) oracle to navigate chemical space? Blueprint: https://t.co/1QCEEpR73k Oracle: https://t.co/i1JLkjAM4E Test it now. Competition goes live this week.

1w ago♥ 35💬 3🔁 3

Mounjaro and Zepbound were 56% of @EliLillyandCo's 2025 revenue. @definiumtx's LSD tablet just got a 2nd FDA Breakthrough designation, this one for depression. Both improve self-regulation, which can impact health, relationships, work and longevity. Agency Therapeutics 🧵

1w ago♥ 32💬 2🔁 2

The distance between intention and action is treated as a question of discipline. GLP-1s, stimulants, psychedelics act on the biology of self-regulation. Agency Therapeutics may be medicine's next major category. Read: thesis, pharmacology, and how we're designing them ↓ https://t.co/FnPIu66bda

1w ago♥ 51💬 2🔁 12

Signal Timeline

0X

@0xKant_ followed

AFirst discovered·1mo ago

Score breakdown0–100

🎯Scout conviction

+18.2 / 35

📚Scout consensus

0 / 10

🪪Profile & earliness

+14 / 20

✍️Substance

+15 / 20

🤖AI verdict

+21.9 / 30

⚠️Penalties

-6 / 40

63

Below threshold (74)
Watching for additional signals.

Followers

4.5K

Account age

1.8y

Scouts

1

First seen

1mo ago